{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:41:34Z","timestamp":1779140494535,"version":"3.51.4"},"reference-count":6,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"DOI":"10.25259\/ijdvl_239_2024","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T12:07:01Z","timestamp":1725106021000},"page":"396-397","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ribociclib induced vitiligo-like lesions"],"prefix":"10.25259","volume":"91","author":[{"given":"Rohit","family":"Kothari","sequence":"first","affiliation":[{"name":"Department of Dermatology, Command Hospital Air Force, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HS","family":"Darling","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology & Haemato-Oncology, Command Hospital Air Force, Bangalore, India,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Command Hospital Air Force, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasa","family":"Janney","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Command Hospital Air Force, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Command Hospital Air Force, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Command Hospital Air Force, Bangalore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"10.25259\/IJDVL_239_2024\/ref-1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40257-021-00645-0","article-title":"Skin toxicities with cyclin-dependent kinase 4\/6 inhibitors in breast cancer: Signals from disproportionality analysis of the FDA adverse event reporting system","volume":"23","author":"Raschi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.25259\/IJDVL_239_2024\/ref-2","doi-asserted-by":"publisher","first-page":"e2022045","DOI":"10.5826\/dpc.1202a45","article-title":"Ribociclib-induced vitiligo: A case report","volume":"12","author":"Silvestre-Torner","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"10.25259\/IJDVL_239_2024\/ref-3","doi-asserted-by":"publisher","first-page":"e248782","DOI":"10.1136\/bcr-2022-248782","article-title":"Ribociclib-induced extensive vitiligo-like lesions: Possible pathomechanisms with clinical, dermoscopic and histological correlation","volume":"15","author":"Anjaneyan","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.25259\/IJDVL_239_2024\/ref-4","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1111\/ajco.13585","article-title":"Drug induced vitiligo-like depigmentation from a CDK 4\/6 inhibitor","volume":"18","author":"Chan","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.25259\/IJDVL_239_2024\/ref-5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2147\/CCID.S344867","article-title":"Vitiligo-like lesions in a patient with metastatic breast cancer treated with cyclin-dependent kinase (CDK) 4\/6 inhibitor: A case report and literature review","volume":"15","author":"Sharaf","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.25259\/IJDVL_239_2024\/ref-6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10549-020-05914-w","article-title":"European Network for cutaneous adverse event of oncologic drugs (ENCADO) group. Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors","volume":"185","author":"Sollena","year":"2021","journal-title":"Breast Cancer Res Treat"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/ribociclib-induced-vitiligo-like-lesions\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/ribociclib-induced-vitiligo-like-lesions\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:20:27Z","timestamp":1745036427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/ribociclib-induced-vitiligo-like-lesions\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":6,"alternative-id":["10.25259\/IJDVL_239_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_239_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"article-number":"396"}}